Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study
Journal
Arthritis and rheumatism
Journal Volume
65
Journal Issue
3
Pages
559
Date Issued
2013-03
Author(s)
van der Heijde, Désirée
Tanaka, Yoshiya
Fleischmann, Roy
Keystone, Edward
Kremer, Joel
Zerbini, Cristiano
Cardiel, Mario H
Cohen, Stanley
Nash, Peter
Song, Yeong-Wook
Tegzová, Dana
Wyman, Bradley T
Gruben, David
Benda, Birgitta
Wallenstein, Gene
Krishnaswami, Sriram
Zwillich, Samuel H
Bradley, John D
Connell, Carol A
Abstract
The purpose of this 24-month phase III study was to examine structural preservation with tofacitinib in patients with rheumatoid arthritis (RA) with an inadequate response to methotrexate (MTX). Data from a planned 12-month interim analysis are reported.
Type
journal article